https://drtalk-hematology.simplecast.com 2026-03-31 1 https://drtalk-hematology.simplecast.com/episodes 2026-03-31 0.9 https://drtalk-hematology.simplecast.com/episodes/mieloma-multiplo-e-decisioni-terapeutiche-limpatto-degli-indicatori-di-qualita-di-vita-LF9fVh3R 2026-03-31 0.8 https://drtalk-hematology.simplecast.com/episodes/rischio-infettivo-e-strategie-vaccinali-in-oncoematologia-jG9otMaM 2026-03-10 0.8 https://drtalk-hematology.simplecast.com/episodes/oltre-la-risposta-il-ruolo-della-malattia-minima-residua-nel-mieloma-multiplo-yGkNJjGW 2026-02-26 0.8 https://drtalk-hematology.simplecast.com/episodes/il-burden-dellanemia-nella-mielofibrosi-implicazioni-cliniche-e-qualita-di-vita-CDzhvl7T 2026-01-29 0.8 https://drtalk-hematology.simplecast.com/episodes/ridefinire-il-rischio-nel-mieloma-multiplo-valore-clinico-delle-alterazioni-citogenetiche-staDfxzc 2025-12-18 0.8 https://drtalk-hematology.simplecast.com/episodes/sequencing-terapeutico-nel-mieloma-multiplo-le-nuove-linee-guida-17esA8mA 2025-12-03 0.8 https://drtalk-hematology.simplecast.com/episodes/emergenze-in-oncoematologia-protocolli-e-decisioni-time-sensitive-i1aq4wQF 2025-11-25 0.8 https://drtalk-hematology.simplecast.com/episodes/unmet-needs-nel-mieloma-multiplo-il-nodo-della-doppia-refrattarieta-tkc7QRFB 2025-11-13 0.8 https://drtalk-hematology.simplecast.com/episodes/intelligenza-artificiale-in-oncoematologia-prospettive-e-implicazioni-cliniche-0wSk0SZj 2025-11-13 0.8 https://drtalk-hematology.simplecast.com/episodes/jak-inhibitors-nel-trattamento-della-mielofibrosi-lo-stato-dellarte-X2B76Ek5 2025-09-25 0.8 https://drtalk-hematology.simplecast.com/episodes/i-trial-clinici-per-la-leucemia-linfatica-cronica-MVcBb0WD 2024-10-29 0.8 https://drtalk-hematology.simplecast.com/episodes/gestione-degli-eventi-avversi-nel-trattamento-della-cll-lo-stato-dellarte-WF8TnWmq 2024-07-11 0.8 https://drtalk-hematology.simplecast.com/episodes/trattamento-di-seconda-linea-della-cll-strategie-terapeutiche-jWrmgR6J 2024-06-25 0.8 https://drtalk-hematology.simplecast.com/episodes/trattamento-di-prima-linea-nella-leucemia-linfatica-cronica-il-punto-HHR_TtEb 2024-04-19 0.8 https://drtalk-hematology.simplecast.com/episodes/impatto-del-mieloma-multiplo-sulla-spesa-sanitaria-t6DnJoa9 2024-01-11 0.8 https://drtalk-hematology.simplecast.com/episodes/meccanismi-di-immunomodulazione-degli-anti-cd38-HxGao0pJ 2023-12-05 0.8 https://drtalk-hematology.simplecast.com/episodes/il-ruolo-del-trapianto-nel-mm-5IdVJ1MV 2023-11-30 0.8 https://drtalk-hematology.simplecast.com/episodes/meccanismi-dazione-e-terapia-a-durata-fissa-Jj6WDFMH 2023-11-30 0.8 https://drtalk-hematology.simplecast.com/episodes/cll-e-unmet-medical-needs-TgQMPSqr 2023-10-10 0.8 https://drtalk-hematology.simplecast.com/episodes/digital-health-in-oncoematologia-tutti-i-vantaggi-di-rita-VlHr6HcI 2023-09-26 0.8 https://drtalk-hematology.simplecast.com/episodes/mrd-negativita-nella-stratificazione-prognostica-del-mieloma-multiplo-il-punto-yG9oJqa_ 2023-09-18 0.8 https://drtalk-hematology.simplecast.com/episodes/insufficienza-renale-nel-mieloma-multiplo-lo-stato-dellarte-ESvn8B__ 2023-05-29 0.8 https://drtalk-hematology.simplecast.com/episodes/il-supporto-psicologico-nel-mieloma-multiplo-una-parte-integrante-del-percorso-di-cura-xU7y6bqD 2023-04-18 0.8 https://drtalk-hematology.simplecast.com/episodes/vivere-con-la-mastocitosi-sistemica-la-testimonianza-di-giorgia-1MUaObn1 2023-03-16 0.8 https://drtalk-hematology.simplecast.com/episodes/compliance-e-aderenza-terapeutica-nel-mieloma-multiplo-recidivato-o-refrattario-2UyGUMxr 2023-02-21 0.8 https://drtalk-hematology.simplecast.com/episodes/ruolo-dellambulatorio-multidisciplinare-nella-mastocitosi-sistemica-_CjT1RX9 2022-12-22 0.8 https://drtalk-hematology.simplecast.com/episodes/refrattarieta-a-lenalidomide-un-supporto-dalle-terapie-di-combinazione-6q_5IgFY 2022-11-14 0.8 https://drtalk-hematology.simplecast.com/episodes/pdta-strumento-prezioso-nella-gestione-della-mastocitosi-sistemica-DeY3JS46 2022-10-25 0.8 https://drtalk-hematology.simplecast.com/episodes/anomalie-genetiche-nel-mieloma-ad-alto-rischio-unoverview-RuxSxe8e 2022-10-20 0.8 https://drtalk-hematology.simplecast.com/episodes/algoritmo-di-terapia-del-paziente-anziano-con-mmrr-YB4rGMWq 2022-10-04 0.8 https://drtalk-hematology.simplecast.com/episodes/approccio-multidisciplinare-e-reti-di-patologia-nel-futuro-della-mastocitosi-sistemica-ZvUymny_ 2022-09-26 0.8 https://drtalk-hematology.simplecast.com/episodes/medicina-di-precisone-punto-di-svolta-nellapproccio-alla-mastocitosi-sistemica-7tAdzvG1 2022-05-30 0.8 https://drtalk-hematology.simplecast.com/episodes/analisi-mutazionale-nella-diagnosi-di-mastocitosi-sistemica-ZIkJZN_K 2022-04-28 0.8 https://drtalk-hematology.simplecast.com/episodes/ruolo-della-mrd-nel-trattamento-del-mieloma-multiplo-nHnTCwMo 2022-04-28 0.8 https://drtalk-hematology.simplecast.com/episodes/insufficienza-renale-nel-mieloma-multiplo-a-che-punto-siamo-uTjEIn9d 2022-09-09 0.8